Inpharma Weekly

, Volume 1171, Issue 1, pp 3–4 | Cite as

A stealthy approach to antineoplastic therapy

  • Sophie Waghorn
Newsletter Article
  • 3 Downloads

Abstract

Liposomal delivery mechanisms are increasingly being seen as a useful vehicle to deliver drugs to the body. A new liposomal formulation has been developed to enable specific targeting of chemotherapy to tumours, delegates were told at the 23rd European Society for Medical Oncology Congress [ Athens, Greece; November 1998 ]. Pegylated-liposomal doxorubicin appears to have superior efficacy over existing therapies in Kaposi’s sarcoma, and evidence is starting to show that it is active in other cancers.

Keywords

Doxorubicin Bleomycin Vinblastine Liposomal Doxorubicin Liposomal Formulation 

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Sophie Waghorn

There are no affiliations available

Personalised recommendations